Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06403761
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-03
Brief Title:
Investigating How CagriSema Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetes Mellitus Type 2 |
Keywords: